(Q46501753)

22 December 2017

title

Use of antibiotics for the treatment of multiresistant gram positive cocci infections in critical patients (English)

1 reference

22 December 2017

main subject

gram-positive bacteria

0 references

multiple drug resistance

1 reference

O Rodríguez Colomo

1

1 reference

22 December 2017

F Alvarez Lerma

2

1 reference

22 December 2017

B Alvarez Sánchez

3

1 reference

22 December 2017

R Oltra Chordá

4

1 reference

22 December 2017

F Barcenilla Gaite

5

1 reference

22 December 2017

E Cereijo Martín-Grande

6

1 reference

22 December 2017

J Cuñat de la Hoz

7

1 reference

22 December 2017

A Martínez Pellús

8

1 reference

22 December 2017

Study Group on the use of active antibiotics against multiresistant gram positive cocci in critical patients

9

1 reference

22 December 2017

publication date

1 August 2008

1 reference

22 December 2017

Medicina intensiva / Sociedad Española de Medicina Intensiva y Unidades Coronarias

published in

1 reference

22 December 2017

volume

32

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

263-271

1 reference

22 December 2017

[Antimicrobial use in Spanish hospitals (EPINE, 1990-1999)].

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC)

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

National Study of Control of Nosocomial Infection in Intensive Care Units. Evolutive report of the years 2003-2005

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

[Antimicrobial resistance surveillance: VIRA STUDY 2006].

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Staphylococcus aureus nosocomial infections in critically ill patients admitted in intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Problems and current solutions for the treatment of infections caused by gram-positive microorganisms

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Oxazolidinones and glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Limitations of presently available glycopeptides in the treatment of Gram-positive infection

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

The oxazolidinones as a new family of antimicrobial agent

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Linezolid: pharmacokinetic characteristics and clinical studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Use of real-time polymerase chain reaction for identification of methicillin-resistant Staphylococcus aureus directly from positive blood culture bottles

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

A critical review of the dosage of teicoplanin in Europe and the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

Penetration of vancomycin into human lung tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

[Optimal vancomycin serum level in Staphylococcus aureus infections?]

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5691%2808%2970953-7

7 January 2021

10.1016/S0210-5691(08)70953-7

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017